Literature DB >> 27468696

Predictors of anticoagulation quality in 15 834 patients performing patient self-management of oral anticoagulation with vitamin K antagonists in real-life practice: a survey of the International Self-Monitoring Association of Orally Anticoagulated Patients.

Christian Schaefer1, Walter A Wuillemin2,3, Alfons Kessels4, Alan Jacobson5, Michael Nagler6,7.   

Abstract

Although patient self-management (PSM) of oral anticoagulation with vitamin K antagonists is recommended for patients requiring long-term anticoagulation, important aspects are still unclear. Using data from a large international survey (n = 15 834; median age 72 years; 30·1% female), we studied predictors of poor anticoagulation control (percentage of International Normalized Ratio values within therapeutic range below 75%) and developed a simple prediction model. The following variables were identified as risk factors for poor anticoagulation control and included in the final model: higher intensity of therapeutic range (odds ratio [OR] on every level 1·9; 95% confidence interval [CI] 1·8-2·0), long intervals between measurements (>14 d; 1·5; 95% CI 1·3-1·7), female sex (OR 1·3; 95% CI 1·2-1·4), and management other than PSM (OR 1·4; 95% CI 1·2-1·6). At a threshold of 0·2 (at least one variable present), the model predicted poor anticoagulation control with a sensitivity of 85·3% (95% CI: 84·0, 86·4) and a specificity of 28·5% (27·6, 29·5). The area under the receiver operated characteristic curve was 0·65. Using the proposed prediction model, physicians will be able to identify patients with a low chance of performing well, considering additional training, regular follow-up, or adjustment of therapeutic ranges.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  International Normalized Ratio; anticoagulant administration/dosage; drug monitoring; self care; vitamin K antagonists/inhibitors

Mesh:

Substances:

Year:  2016        PMID: 27468696     DOI: 10.1111/bjh.14273

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  4 in total

Review 1.  Optimizing quality care for the oral vitamin K antagonists (VKAs).

Authors:  Vittorio Pengo; Gentian Denas
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

2.  American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy.

Authors:  Daniel M Witt; Robby Nieuwlaat; Nathan P Clark; Jack Ansell; Anne Holbrook; Jane Skov; Nadine Shehab; Juliet Mock; Tarra Myers; Francesco Dentali; Mark A Crowther; Arnav Agarwal; Meha Bhatt; Rasha Khatib; John J Riva; Yuan Zhang; Gordon Guyatt
Journal:  Blood Adv       Date:  2018-11-27

3.  Does a complex intervention increase patient knowledge about oral anticoagulation? - a cluster-randomised controlled trial.

Authors:  Verena Maikranz; Andrea Siebenhofer; Lisa-R Ulrich; Karola Mergenthal; Sylvia Schulz-Rothe; Birgit Kemperdick; Sandra Rauck; Gudrun Pregartner; Andrea Berghold; Ferdinand M Gerlach; Juliana J Petersen
Journal:  BMC Fam Pract       Date:  2017-02-07       Impact factor: 2.497

4.  Impact of self-funding on patient experience of oral anticoagulation self-monitoring: a qualitative study.

Authors:  Alice Tompson; Carl Heneghan; Stephen Sutton; David Fitzmaurice; Alison Ward
Journal:  BMJ Open       Date:  2016-12-23       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.